{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:08:31Z","timestamp":1778810911966,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00345-020-03130-1","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T18:02:50Z","timestamp":1582048970000},"page":"3177-3182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer"],"prefix":"10.1007","volume":"38","author":[{"given":"Wojciech","family":"Krajewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Rodr\u00edguez Faba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Breda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir","family":"Poletajew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Tukiendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romuald","family":"Zdrojowy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ko\u0142odziej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Palou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"3130_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, Bohle A, Burger M et al (2017) eau guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447\u2013461. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.041","journal-title":"Eur Urol"},{"key":"3130_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1442-2042.2007.01696.x","volume":"14","author":"Y Shintani","year":"2007","unstructured":"Shintani Y, Sawada Y, Inagaki T et al (2007) Intravesical instillation therapy with bacillus Calmette\u2013Guerin for superficial bladder cancer: study of the mechanism of bacillus Calmette\u2013Guerin immunotherapy. Int J Urol 14:140\u2013146. https:\/\/doi.org\/10.1111\/j.1442-2042.2007.01696.x","journal-title":"Int J Urol"},{"key":"3130_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1474-9728.2004.00106.x","volume":"3","author":"B DeVeale","year":"2004","unstructured":"DeVeale B, Brummel T, Seroude L (2004) Immunity and aging: the enemy within? Aging Cell 3:195\u2013208. https:\/\/doi.org\/10.1111\/j.1474-9728.2004.00106.x","journal-title":"Aging Cell"},{"key":"3130_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000156477","volume":"15","author":"G Pfister","year":"2008","unstructured":"Pfister G, Savino W (2008) Can the immune system still be efficient in the elderly? An immunological and immunoendocrine therapeutic perspective. NeuroImmunoModulation 15:351\u2013364. https:\/\/doi.org\/10.1159\/000156477","journal-title":"NeuroImmunoModulation"},{"key":"3130_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.urology.2007.03.024","volume":"70","author":"HW Herr","year":"2007","unstructured":"Herr HW (2007) Age and outcome of superficial bladder cancer treated with bacille Calmette\u2013Guerin therapy. Urology 70:65\u201368. https:\/\/doi.org\/10.1016\/j.urology.2007.03.024","journal-title":"Urology"},{"key":"3130_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.urology.2011.04.070","volume":"78","author":"D Margel","year":"2011","unstructured":"Margel D, Alkhateeb SS, Finelli A et al (2011) Diminished efficacy of bacille Calmette\u2013Guerin among elderly patients with nonmuscle invasive bladder cancer. Urology 78:848\u2013854. https:\/\/doi.org\/10.1016\/j.urology.2011.04.070","journal-title":"Urology"},{"key":"3130_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/jjco\/hyq241","volume":"41","author":"K Yuge","year":"2011","unstructured":"Yuge K, Kikuchi E, Matsumoto K et al (2011) Could patient age influence tumor recurrence rate in non-muscle-invasive bladder cancer patients treated with BCG immunotherapy? Jpn J Clin Oncol 41:565\u2013570. https:\/\/doi.org\/10.1093\/jjco\/hyq241","journal-title":"Jpn J Clin Oncol"},{"key":"3130_CR8","doi-asserted-by":"publisher","first-page":"e16223","DOI":"10.1097\/MD.0000000000016223","volume":"98","author":"B Calo","year":"2019","unstructured":"Calo B, Sanguedolce F, Fortunato F et al (2019) The impact of age on intravesical instillation of bacille Calmette\u2013Guerin treatment in patients with high-grade T1 bladder cancer. Medicine (Baltimore) 98:e16223. https:\/\/doi.org\/10.1097\/MD.0000000000016223","journal-title":"Medicine (Baltimore)"},{"key":"3130_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.eururo.2014.05.033","volume":"66","author":"JR Oddens","year":"2014","unstructured":"Oddens JR, Sylvester RJ, Brausi MA et al (2014) The effect of age on the efficacy of maintenance bacillus Calmette\u2013Guerin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911. Eur Urol 66:694\u2013701. https:\/\/doi.org\/10.1016\/j.eururo.2014.05.033","journal-title":"Eur Urol"},{"key":"3130_CR10","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/sim.3532","volume":"28","author":"A Sjolander","year":"2009","unstructured":"Sjolander A (2009) Propensity scores and M-structures. Stat Med 28:1416\u20131420. https:\/\/doi.org\/10.1002\/sim.3532 (author reply 1420\u20131413)","journal-title":"Stat Med"},{"key":"3130_CR11","unstructured":"Team RC (2017) A language and environment for statistical computing Vienna, Austria2017 [cited 2017 21.08.2017]. https:\/\/www.R-project.org. Accessed July 2019"},{"key":"3130_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:465\u2013466. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.031(discussion 475\u2013467)","journal-title":"Eur Urol"},{"key":"3130_CR13","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E et al (2009) Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette\u2013Guerin: the CUETO scoring model. J Urol 182:2195\u20132203. https:\/\/doi.org\/10.1016\/j.juro.2009.07.016","journal-title":"J Urol"},{"key":"3130_CR14","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","volume":"175","author":"FN Joudi","year":"2006","unstructured":"Joudi FN, Smith BJ, O'Donnell MA et al (2006) The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy. J Urol 175:1634\u20131639. https:\/\/doi.org\/10.1016\/S0022-5347(05)00973-0 (discussion 1639\u20131640)","journal-title":"J Urol"},{"key":"3130_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.urolonc.2007.04.005","volume":"26","author":"JG Heiner","year":"2008","unstructured":"Heiner JG, Terris MK (2008) Effect of advanced age on the development of complications from intravesical bacillus Calmette\u2013Guerin therapy. Urol Oncol 26:137\u2013140. https:\/\/doi.org\/10.1016\/j.urolonc.2007.04.005","journal-title":"Urol Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-020-03130-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T11:07:30Z","timestamp":1613732850000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-020-03130-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3130"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03130-1","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"29 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This is retrospective observation. Informed consent was obtained from all individual participants at the time of their BCG therapy onset, stating that in future, their data may be included in the scientific studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}